REGENXBIO's Nina Hunter, Ph.D. Details The Accelerated Approval Pathway For Gene Therapies
Source: Cell & Gene
REGENXBIO's VP of Regulatory and Science Policy, Nina Hunter, Ph.D., shares potential solutions to gene therapies' regulatory roadblocks and why the accelerated approval pathway is so pertinent.
This website uses cookies to ensure you get the best experience on our website. Learn more